Subtopic Deep Dive
Fibrin Sealants
Research Guide
What is Fibrin Sealants?
Fibrin sealants are biological adhesives composed of fibrinogen and thrombin that polymerize to form a fibrin clot for hemostasis and tissue sealing in surgical procedures.
Fibrin sealants mimic the final stage of coagulation to achieve rapid hemostasis in cardiovascular and orthopedic surgeries (Spotnitz, 2014). Research examines synthetic and autologous formulations, with over 300 cited papers on their mechanisms and clinical outcomes. Key studies report reduced blood loss and operative time using FDA-approved products (Spotnitz, 2014; Everts et al., 2006).
Why It Matters
Fibrin sealants reduce blood loss by up to 50% in thoracoabdominal aortic aneurysm surgery, guiding fibrinogen concentrate administration via thromboelastometry (Rahe-Meyer et al., 2009). In cardiovascular procedures, strongly adhesive hydrogels from fibrin-like systems repair arterial bleeds, shortening operative times (Hong et al., 2019). These agents lower transfusion needs in orthopedic and trauma settings, influencing minimally invasive surgery guidelines (Spotnitz, 2014; Seyednejad et al., 2008).
Key Research Challenges
Weak Wet Tissue Adhesion
Fibrin sealants exhibit poor adhesion to wet, mobile tissues like arterial walls, limiting efficacy in high-pressure bleeds (Hong et al., 2019). Studies show embolization risks from inadequate polymerization under hemodynamic stress. Hydrogel enhancements address this but require biocompatibility testing (Pourshahrestani et al., 2020).
Durability in Dynamic Environments
Sealants degrade prematurely in beating heart or orthopedic stress sites, leading to re-bleeding (Spotnitz, 2014). Research identifies thrombin concentration and fibrinogen sourcing as key to clot stability. Clinical trials report variable durability across autologous versus synthetic glues (Everts et al., 2006).
Embolization and Complication Rates
Fragmentation risks embolization in vascular surgeries, with complication rates up to 10% in early formulations (Seyednejad et al., 2008). Balancing rapid polymerization with controlled degradation remains unsolved. Advanced monitoring like thromboelastometry aids dosing but needs standardization (Rahe-Meyer et al., 2009).
Essential Papers
A strongly adhesive hemostatic hydrogel for the repair of arterial and heart bleeds
Yi Hong, Feifei Zhou, Yujie Hua et al. · 2019 · Nature Communications · 783 citations
Abstract Uncontrollable bleeding is a major problem in surgical procedures and after major trauma. Existing hemostatic agents poorly control hemorrhaging from traumatic arterial and cardiac wounds ...
Platelet-Rich Plasma and Platelet Gel: A Review
Peter A. Everts, Johannes T. A. Knape, Gernot Weibrich et al. · 2006 · Journal of ExtraCorporeal Technology · 563 citations
Strategies to reduce blood loss and transfusion of allogeneic blood products during surgical procedures are important in modern times. The most important and well-known autologous techniques are pr...
Platelets and wound healing
T Nurden Alan · 2008 · Frontiers in bioscience · 516 citations
Platelets help prevent blood loss at sites of vascular injury. To do this, they adhere, aggregate and form a procoagulant surface favoring thrombin generation and fibrin formation. In addition, pla...
Polymeric Hydrogel Systems as Emerging Biomaterial Platforms to Enable Hemostasis and Wound Healing
Sara Pourshahrestani, Ehsan Zeimaran, Nahrizul Adib Kadri et al. · 2020 · Advanced Healthcare Materials · 371 citations
Abstract Broad interest in developing new hemostatic technologies arises from unmet needs in mitigating uncontrolled hemorrhage in emergency, surgical, and battlefield settings. Although a variety ...
Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive—a Laboratory and Clinical Perspective
William D. Spotnitz · 2014 · ISRN Surgery · 335 citations
Background. Fibrin sealant became the first modern era material approved as a hemostat in the United States in 1998. It is the only agent presently approved as a hemostat, sealant, and adhesive by ...
A natural biological adhesive from snail mucus for wound repair
Tuo Deng, Dongxiu Gao, Xuemei Song et al. · 2023 · Nature Communications · 235 citations
Injectable Self-Healing Adhesive pH-Responsive Hydrogels Accelerate Gastric Hemostasis and Wound Healing
Jiahui He, Zixi Zhang, Yutong Yang et al. · 2021 · Nano-Micro Letters · 235 citations
Reading Guide
Foundational Papers
Start with Spotnitz (2014) for FDA approval history and clinical perspective on fibrin as the only approved hemostat-sealant-adhesive; Everts et al. (2006) for autologous platelet gel techniques; Nurden (2008) for platelet roles in fibrin formation and wound healing.
Recent Advances
Hong et al. (2019) for adhesive hydrogels repairing arterial bleeds (783 citations); Pourshahrestani et al. (2020) for polymeric systems enabling hemostasis; He et al. (2021) for pH-responsive injectable hydrogels.
Core Methods
Core techniques involve fibrinogen-thrombin mixing for polymerization (Spotnitz, 2014), thromboelastometry-guided dosing (Rahe-Meyer et al., 2009), and hydrogel crosslinking for adhesion (Hong et al., 2019).
How PapersFlow Helps You Research Fibrin Sealants
Discover & Search
PapersFlow's Research Agent uses searchPapers and citationGraph to map 300+ papers on fibrin sealants, starting from Spotnitz (2014) with 335 citations to trace FDA approvals and clinical perspectives. exaSearch uncovers niche autologous formulations, while findSimilarPapers links Hong et al. (2019) to hydrogel advances.
Analyze & Verify
Analysis Agent employs readPaperContent on Hong et al. (2019) to extract adhesion metrics, then verifyResponse with CoVe checks claims against Rahe-Meyer et al. (2009). runPythonAnalysis processes thromboelastometry data from papers via pandas for bleeding reduction stats, with GRADE grading for evidence quality in hemostasis trials.
Synthesize & Write
Synthesis Agent detects gaps in embolization prevention across Spotnitz (2014) and Pourshahrestani et al. (2020), flagging contradictions in durability claims. Writing Agent uses latexEditText and latexSyncCitations to draft reviews with Hong et al. (2019), latexCompile for publication-ready output, and exportMermaid for polymerization mechanism diagrams.
Use Cases
"Analyze hemostatic efficacy data from fibrin sealant trials using Python."
Research Agent → searchPapers('fibrin sealants thromboelastometry') → Analysis Agent → readPaperContent(Rahe-Meyer 2009) → runPythonAnalysis(pandas plot blood loss reduction stats) → matplotlib graph of fibrinogen dosing outcomes.
"Write a LaTeX review on fibrin glue complications in cardiac surgery."
Synthesis Agent → gap detection(Spotnitz 2014 + Hong 2019) → Writing Agent → latexEditText(intro section) → latexSyncCitations(Everts 2006) → latexCompile → PDF with inline citations and tables.
"Find code for simulating fibrin polymerization models."
Research Agent → searchPapers('fibrin sealant polymerization simulation') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python scripts for clot formation dynamics.
Automated Workflows
Deep Research workflow conducts systematic reviews of 50+ hemostasis papers, chaining citationGraph from Everts et al. (2006) to recent hydrogels for structured reports on sealant evolution. DeepScan applies 7-step analysis with CoVe checkpoints to verify adhesion claims in Hong et al. (2019). Theorizer generates hypotheses on bioengineered fibrin durability from Spotnitz (2014) and Pourshahrestani et al. (2020).
Frequently Asked Questions
What defines fibrin sealants?
Fibrin sealants combine fibrinogen and thrombin to form a clot mimicking coagulation, approved by FDA as hemostats, sealants, and adhesives (Spotnitz, 2014).
What are common methods in fibrin sealant research?
Methods include autologous platelet-rich plasma gels (Everts et al., 2006) and synthetic hydrogels with strong wet adhesion (Hong et al., 2019), tested via thromboelastometry (Rahe-Meyer et al., 2009).
What are key papers on fibrin sealants?
Spotnitz (2014, 335 citations) details FDA-approved uses; Hong et al. (2019, 783 citations) introduces adhesive hydrogels; Everts et al. (2006, 563 citations) reviews platelet gels.
What open problems exist in fibrin sealants?
Challenges include wet tissue adhesion failure and embolization risks in dynamic surgeries (Hong et al., 2019; Seyednejad et al., 2008), needing durable bioengineered solutions.
Research Hemostasis and retained surgical items with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Fibrin Sealants with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers